1 Min Read
April 27 (Reuters) - 3D Signatures Inc:
* 3D Signatures receives first prostate cancer blood samples for precise clinical trial Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.